Ocular Therapeutix Inc (OCUL)

[Jonas3]

I think the results, although ok, didn't paint a good financial model. For example, their glaucoma medicine did not meet a primary objective to remove redness in eyes. This is not a concern to the FDA, but most likely is to consumers who are looking for a quality product. Even with FDA approval, consumers still need to buy the product.

Basically, I think Ocular realized that they need to tweak their medicine to be competitive in the marketplace, and will require patience. The stock price reflects that.

The good news is that 4 analysts have the price as a buy and the other 2 list it as a hold. Personally, I was looking at buying at 9.40 (but thankfully didn't), but now I think the pps could go either way with bearish momentum being the catalyst for a price drop and bounce potential, overselling and long term potential of the company being a catalyst for a bounce. I'm going to watch the price on Monday and I may be tempted to buy if there is a bearish surge.